• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tumor growth rate and prognosis of breast cancer mainly detected by mass screening.乳腺癌的肿瘤生长速率和预后主要通过群体筛查来检测。
Jpn J Cancer Res. 1990 May;81(5):454-62. doi: 10.1111/j.1349-7006.1990.tb02591.x.
2
[Radiation therapy for brain metastases from breast cancer by histological classification].[乳腺癌脑转移瘤组织学分类的放射治疗]
Nihon Igaku Hoshasen Gakkai Zasshi. 2001 Feb;61(3):89-95.
3
Ultrasound examination is useful for prediction of histologic type in invasive ductal carcinoma of the breast.超声检查有助于预测乳腺浸润性导管癌的组织学类型。
Ultrasound Med Biol. 2008 Apr;34(4):517-24. doi: 10.1016/j.ultrasmedbio.2007.09.017. Epub 2007 Nov 28.
4
[Factors influencing on the prognosis in breast cancer].[影响乳腺癌预后的因素]
Gan To Kagaku Ryoho. 1988 Jul;15(7):2043-9.
5
[Hydroxyproline in breast cancer].[乳腺癌中的羟脯氨酸]
Nihon Geka Gakkai Zasshi. 1989 Jun;90(6):914-9.
6
Breast cancer--influence of growth rate on prognosis and treatment evaluation: a study based on mastectomy scar recurrences.
Cancer. 1976 Oct;38(4):1826-33. doi: 10.1002/1097-0142(197610)38:4<1826::aid-cncr2820380460>3.0.co;2-l.
7
[Reevaluation of the histological classification of breast cancer--a presentation of a new histological classification considering the relationship between scirrhous tendency and postoperative prognosis].[乳腺癌组织学分类的重新评估——一种考虑硬癌倾向与术后预后关系的新组织学分类方法介绍]
Nihon Geka Gakkai Zasshi. 1985 Jul;86(7):853-62.
8
[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].10枚及以上阳性淋巴结的女性乳腺癌患者的临床特征及预后因素:128例报告
Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):77-81.
9
Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.在一家机构接受保乳治疗的乳腺癌患者中,管理技术的变化以及疾病复发模式随时间的变化情况。
Cancer. 2004 Aug 15;101(4):713-20. doi: 10.1002/cncr.20410.
10
The characteristics of interval breast cancer in mass screening.
Tokushima J Exp Med. 1992 Dec;39(3-4):109-16.

引用本文的文献

1
Tumor Growth Rate in Neuroendocrine Neoplasms: An Additional Tool for Treatment Strategies?
Medicina (Kaunas). 2025 Oct 16;61(10):1852. doi: 10.3390/medicina61101852.
2
The prognostic potential of mammographic growth rate of invasive breast cancer in the Nijmegen breast cancer screening cohort.乳腺 X 线摄影检查中浸润性乳腺癌生长率的预后预测价值:奈梅亨乳腺癌筛查队列研究
J Med Screen. 2024 Sep;31(3):166-175. doi: 10.1177/09691413231222765. Epub 2024 Jan 31.
3
Demographic and pathologic factor regression to a growth rate model of p16-negative oral cavity squamous cell carcinoma.人口统计学和病理学因素回归至p16阴性口腔鳞状细胞癌的生长率模型。
Laryngoscope Investig Otolaryngol. 2022 Aug 16;7(5):1384-1390. doi: 10.1002/lio2.831. eCollection 2022 Oct.
4
Has tumor doubling time in breast cancer changed over the past 80 years? A systematic review.乳腺癌的肿瘤倍增时间在过去 80 年中是否发生了变化?一项系统评价。
Cancer Med. 2021 Aug;10(15):5203-5217. doi: 10.1002/cam4.3939. Epub 2021 Jul 15.
5
A Mathematical Model to Predict Diagnostic Periods for Secondary Distant Metastases in Patients with ER/PR/HER2/Ki-67 Subtypes of Breast Cancer.一种预测雌激素受体/孕激素受体/人表皮生长因子受体2/ Ki-67亚型乳腺癌患者继发性远处转移诊断期的数学模型。
Cancers (Basel). 2020 Aug 19;12(9):2344. doi: 10.3390/cancers12092344.
6
Cancer recurrence times from a branching process model.从分支过程模型看癌症复发次数。
PLoS Comput Biol. 2019 Nov 21;15(11):e1007423. doi: 10.1371/journal.pcbi.1007423. eCollection 2019 Nov.
7
Timescale of tumor volume of a young breast cancer patient with luminal B subtype: A case report.一名年轻的luminal B亚型乳腺癌患者肿瘤体积的时间尺度:病例报告。
Medicine (Baltimore). 2019 Oct;98(43):e17659. doi: 10.1097/MD.0000000000017659.
8
Bovine leukemia virus DNA associated with breast cancer in women from South Brazil.与南巴西南部妇女乳腺癌相关的牛白血病病毒 DNA。
Sci Rep. 2019 Feb 27;9(1):2949. doi: 10.1038/s41598-019-39834-7.
9
Estimation of Solid Tumor Doubling Times from Progression-Free Survival Plots Using a Novel Statistical Approach.利用一种新的统计方法从无进展生存期图估算实体瘤倍增时间。
AAPS J. 2019 Feb 8;21(2):27. doi: 10.1208/s12248-019-0302-5.
10
Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.肿瘤体积倍增时间作为肝细胞癌患者的动态预后标志物
Dig Dis Sci. 2017 Oct;62(10):2923-2931. doi: 10.1007/s10620-017-4708-6. Epub 2017 Aug 16.

本文引用的文献

1
DYNAMICS OF TUMOUR GROWTH: COMPARISON OF GROWTH RATES AND EXTRAPOLATION OF GROWTH CURVE TO ONE CELL.肿瘤生长动力学:生长速率比较及生长曲线外推至单个细胞
Br J Cancer. 1965 Jun;19(2):278-91. doi: 10.1038/bjc.1965.32.
2
ROENTGENOGRAPHY OF BREAST CANCER MODERATING CONCEPT OF "BIOLOGIC PREDETERMINISM".乳腺癌的X线摄影术:对“生物预定论”概念的修正
Cancer. 1963 Aug;16:961-4. doi: 10.1002/1097-0142(196308)16:8<961::aid-cncr2820160802>3.0.co;2-b.
3
A biomathematical approach to clinical tumor growth.一种临床肿瘤生长的生物数学方法。
Cancer. 1961 Nov-Dec;14:1272-94. doi: 10.1002/1097-0142(196111/12)14:6<1272::aid-cncr2820140618>3.0.co;2-h.
4
Observations on growth rates of human tumors.关于人类肿瘤生长速率的观察
Am J Roentgenol Radium Ther Nucl Med. 1956 Nov;76(5):988-1000.
5
Growth rate of 147 mammary carcinomas.147例乳腺癌的生长速率
Cancer. 1980 Apr 15;45(8):2198-2207. doi: 10.1002/1097-0142(19800415)45:8<2198::aid-cncr2820450832>3.0.co;2-7.
6
Kinetic parameters and the course of the disease in breast cancer.乳腺癌的动力学参数与疾病进程
Cancer. 1981 Mar 1;47(5):937-43. doi: 10.1002/1097-0142(19810301)47:5<937::aid-cncr2820470520>3.0.co;2-6.
7
Rapid growth rate: a method of identifying node-negative breast cancer patients with a high risk of recurrence.
J Chronic Dis. 1983;36(12):847-53. doi: 10.1016/0021-9681(83)90005-x.
8
Association between the actual doubling times of primary breast cancer with histopathologic characteristics and Wolfe's parenchymal mammographic patterns.
Cancer. 1981 May 1;47(9):2265-8. doi: 10.1002/1097-0142(19810501)47:9<2265::aid-cncr2820470927>3.0.co;2-y.
9
The cross rates of growth of human mammary carcinoma.人类乳腺癌的交叉生长率。
Cancer. 1972 Aug;30(2):594-9. doi: 10.1002/1097-0142(197208)30:2<594::aid-cncr2820300241>3.0.co;2-2.
10
The auxometric dimension. A new method for using rate of growth in prognostic staging of breast cancer.辅助测量维度。一种在乳腺癌预后分期中运用生长速率的新方法。
JAMA. 1974 Apr 8;228(2):180-5. doi: 10.1001/jama.228.2.180.

乳腺癌的肿瘤生长速率和预后主要通过群体筛查来检测。

Tumor growth rate and prognosis of breast cancer mainly detected by mass screening.

作者信息

Kuroishi T, Tominaga S, Morimoto T, Tashiro H, Itoh S, Watanabe H, Fukuda M, Ota J, Horino T, Ishida T

机构信息

Division of Epidemiology, Aichi Cancer Center Research Institute, Nagoya.

出版信息

Jpn J Cancer Res. 1990 May;81(5):454-62. doi: 10.1111/j.1349-7006.1990.tb02591.x.

DOI:10.1111/j.1349-7006.1990.tb02591.x
PMID:2116393
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5918060/
Abstract

To investigate the relationship between the tumor growth rate of the primary breast cancer and its prognosis, records for 122 breast cancer patients in 9 hospitals in Japan were retrospectively reviewed. These records contained at least two measurements of the same tumor mass in the breast. So the growth rate was estimated from these measurements taken at different points in time. The doubling time of the breast tumors showed an approximately log-normal distribution. The geometric mean of doubling times for all cases was 174 days. The solid-tubular histologic type of carcinoma had the shortest geometric mean of doubling time (126 days), the scirrhous carcinoma had the second shortest one (205 days), and the papillotubular carcinoma had the longest one (252 days). The patients with shorter doubling time of tumor tended to have a poorer prognosis. The Cox multiple regression analysis showed that the tumor growth rate was related significantly with survival, after adjusting for other covariates such as clinical stage, lymph node metastasis, age of patient, histological type, and year of treatment.

摘要

为了研究原发性乳腺癌的肿瘤生长速率与其预后之间的关系,我们对日本9家医院的122例乳腺癌患者的记录进行了回顾性分析。这些记录包含对乳房中同一肿瘤块至少两次的测量数据。因此,肿瘤生长速率是根据在不同时间点进行的这些测量数据估算得出的。乳腺肿瘤的倍增时间呈近似对数正态分布。所有病例的倍增时间几何平均值为174天。实体-管状组织学类型的癌倍增时间几何平均值最短(126天),硬癌次之(205天),乳头管状癌最长(252天)。肿瘤倍增时间较短的患者往往预后较差。Cox多因素回归分析显示,在对临床分期、淋巴结转移、患者年龄、组织学类型和治疗年份等其他协变量进行校正后,肿瘤生长速率与生存率显著相关。